UPDATE
n° 189 | October 2024
In this issue:

People with cancer still face stigma in return to work

New report on job return from the European Commission
24 Oct 2024

Prostate makes up 12% of all cancer cases in Europe

New analysis of incidence from the European Commission shows cancer cases on the rise
15 Oct 2024

New study supports need for organised screening

Opportunistic PSA testing brings overdiagnosis, IARC analysis says
3 Oct 2024
Prostate Research and Treatments

Testosterone recovery after prostate cancer treatment

A study has shown that testosterone recovery following ADT with gonadotropin-releasing hormone agonists can vary across individuals.

The TRANSPORT study (Testosterone Recovery Following Androgen Suppression and Prostate Radiotherapy) found that recovery time is influenced by the length of ADT treatment, with older age and lower baseline testosterone levels associated with slower recovery. The researchers also found that, for men receiving six months of ADT, maintaining low testosterone levels for approximately 11 months may lead to improved metastasis-free survival, suggesting a longer suppression period may be beneficial even in a shorter ADT regimen

Read the article published in European Urology here.

 

Migration of metastatic prostate cancer

The patterns by which primary tumours spread to metastatic sites are very unclear. A new US study attempts to define tumour clonal patterns and routes of migration in prostate cancer using a novel injection-based mouse model.  Details are published in the journal Cancer Discovery.

ESMO 2024: prostate cancer scientific highlights

You can find an overview of the ESMO 2024 highlights on prostate cancer here.

Microplastics and prostate cancer

A recent article on the News Medical website discusses a study which found three types of microplastics in prostate tumours. The presence of microplastics in prostate tissue raises questions about the potential role of environmental factors in the onset or progression of prostate cancer.

Read the article here.

Europa Uomo News

Look out for our new online EU-PRESS survey on shared decision making

On 1st November, Europa Uomo will launch a new survey on shared decision making, EU-PRESS. Please keep an eye on your mailbox in the coming days for a special Update dedicated to this new survey.

 

Items of Interest

ASPI webinars on active surveillance

Active Surveillance Patients International (ASPI) organises monthly webinars.

All their previous webinars have been recorded and can be found on their website.

FREE SUBSCRIPTION TO EUROPA UOMO MONTHLY UPDATE

All previous issues are available on website: www.europa-uomo.org/newsletters/